Keith Robison has a humorous post on the increasing catchiness of the former nerds-only term "DNA." Any number of companies have started referring to things as being in their DNA, which leads Robison to wonder just what they mean by that. Are they suggesting, he asks, that they have a lot of redundancy, or that "a lot of pieces of the organization resemble decayed portions of other pieces of our organization"? Definitely check it out -- it'll make you laugh.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.